United Therapeutics Corporation (UTHR) Insider Trading

Total insider buys:
  • $999,400.80
Total insider sells:
  • $773,721,457.77
Most recent insider trade:
  • Nov. 11, 2024
Most active insider trader:
  • Martine A Rothblatt
Trader NameDateTitleAmountPriceTypeTotal Value
Nov. 11, 2024Director1,750$412.48Sell$721,840.00
Nov. 11, 2024COO15,000$407.32Sell$6,109,800.00
Nov. 8, 2024Director224$412.28Sell$92,350.72
Nov. 7, 2024COO15,000$401.44Sell$6,021,600.00
Nov. 1, 2024COO14,700$374.46Sell$5,504,562.00
Nov. 1, 2024Director510$376.63Sell$192,081.30
Oct. 28, 2024CFO7,800$350.00Sell$2,730,000.00
Oct. 21, 2024CFO7,782$366.99Sell$2,855,916.18
Oct. 14, 2024CFO7,792$355.88Sell$2,773,016.96
Oct. 7, 2024CFO7,794$355.54Sell$2,771,078.76
Sept. 30, 2024CFO7,792$358.62Sell$2,794,367.04
Sept. 23, 2024CFO7,796$354.04Sell$2,760,095.84
Sept. 9, 2024CFO7,802$345.41Sell$2,694,888.82
Sept. 3, 2024CFO7,785$362.37Sell$2,821,050.45
Aug. 26, 2024CEO269$348.41Sell$93,722.29
Aug. 19, 2024CEO3,600$344.18Sell$1,239,048.00
Aug. 8, 2024CEO3,600$328.39Sell$1,182,204.00
Aug. 7, 2024COO25,000$323.38Sell$8,084,500.00
Aug. 6, 2024CEO3,600$325.45Sell$1,171,620.00
Aug. 2, 2024CEO3,600$324.73Sell$1,169,028.00
Aug. 2, 2024Director5,000$325.35Sell$1,626,750.00
July 30, 2024CEO3,600$337.40Sell$1,214,640.00
July 26, 2024CEO3,600$338.61Sell$1,218,996.00
July 24, 2024CEO3,600$334.00Sell$1,202,400.00
July 22, 2024CEO3,600$331.32Sell$1,192,752.00
July 18, 2024CEO3,600$331.79Sell$1,194,444.00
July 16, 2024CEO3,600$328.03Sell$1,180,908.00
July 12, 2024CEO3,600$324.97Sell$1,169,892.00
July 10, 2024CEO3,600$326.35Sell$1,174,860.00
July 8, 2024CEO3,600$317.05Sell$1,141,380.00
July 5, 2024CEO3,600$313.25Sell$1,127,700.00
July 3, 2024CEO3,600$312.48Sell$1,124,928.00
July 1, 2024CEO3,600$320.45Sell$1,153,620.00
June 27, 2024CEO3,600$316.62Sell$1,139,832.00
June 25, 2024Director266$318.58Sell$84,742.28
June 24, 2024CEO3,600$315.97Sell$1,137,492.00
June 21, 2024CEO3,600$313.91Sell$1,130,076.00
June 14, 2024CEO3,600$287.22Sell$1,033,992.00
June 13, 2024Director2,000$281.53Sell$563,060.00
June 12, 2024CEO3,600$281.19Sell$1,012,284.00
June 10, 2024CEO3,600$273.95Sell$986,220.00
June 7, 2024CEO3,600$277.13Sell$997,668.00
May 31, 2024CEO3,600$272.48Sell$980,928.00
May 28, 2024Director3,600$269.06Sell$968,616.00
May 23, 2024Director3,600$275.78Sell$992,808.00
May 21, 2024Director1,468$275.85Sell$404,947.80
May 16, 2024Director3,600$272.37Sell$980,532.00
May 14, 2024Director1,310$264.35Sell$346,298.50
May 13, 2024CEO3,600$265.48Sell$955,728.00
May 9, 2024CEO3,600$264.22Sell$951,192.00
First«1 of 17»Last
  • Insiders are both buying and selling United Therapeutics Corporation stock.

  • The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, John Maxim Ferrari, Raymond Dwek, Christopher Patusky, Paul Mahon, David Zaccardelli, Richard Giltner, James Edgemond, Nilda Mesa, Louis W Sullivan, Tommy G Thompson, Judy D Olian, Michael Benkowitz, Ray Kurzweil, Paul A. Mahon, Louis Sullivan, R Paul Gray, Judy D. Olian, Tommy G. Thompson, DWEK RAYMOND, and MAHON PAUL A

  • The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.

  • Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.

  • Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.

  • The most recent insider trade for United Therapeutics Corporation was on Nov. 11, 2024.

  • The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.

  • The single biggest insider sell for United Therapeutics Corporation was from Michael Benkowitz with a total value of $8,084,500.00 on Aug. 7, 2024.